Construction of Ferroptosis and Pyroptosis Model to Assess the Prognosis of Gastric Cancer Patients Based on Bioinformatics

Overview

Journal Transl Cancer Res

Specialty Oncology

Date 2024 Dec 19

PMID 39697712

Authors

Hanlu Shi

Hongfeng Yao

Yi Zhou

Gaoping Wu

Keyi Li

Lusheng Tang

Chen Yang

Dong Wang

Weidong Jin

Affiliations

Soon will be listed here.

Abstract

Background: Gastric cancer (GC) is a malignancy with a grim prognosis, ranking as the second most common cause of cancer-related deaths globally. Various investigations have demonstrated the substantial involvement of ferroptosis and pyroptosis in the advancement of tumors. Nevertheless, the precise molecular mechanisms by which distinct genes associated with ferroptosis and pyroptosis influence the tumor microenvironment (TME) in GC remain elusive. Therefore, this study aims to elucidate the role of ferroptosis and pyroptosis in GC and provide insigths for GC therapy and prognosis evaluation.

Methods: The data including gene expression, clinicopathological characteristics and survival information of GC samples from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) cohorts were collected, and the expression level of ferroptosis and pyroptosis genes (FPGs) in GC samples were analyzed. Consensus clustering analysis, Cox logistic regression, principal component analysis (PCA), and the "survival", "survminer", "limma", "ggplot2" and other packages in R were utilized to compare the differences among different groups. In the level of GC cells, cell viability experiments were conducted by Cell Counting Kit-8 (CCK-8) assay.

Results: Through the analysis of the expression level of FPGs in GC samples from the TCGA and GEO cohorts, twenty-three prognostic-related and differentially expressed FPGs were collected for further analysis. Through consensus clustering analysis, three distinct patterns of FPGs were identified and found to be correlated with clinicopathological characteristics, immune cell infiltration, and prognosis in patients with GC. Subsequently, 684 prognostic-related genes from 1,082 pattern-related differentially expressed genes (DEGs) were screened for constructing the FPG_Score system to quantify FPGs patterns in individual GC patients and predict the prognosis. The analysis indicated that GC patients with high FPG_Score exhibited improved survival rates, increased tumor mutation burden (TMB), higher microsatellite instability (MSI), and elevated programmed cell death protein ligand 1 (PD-L1) expression. These patients with high FPG_Score were more likely to benefit from immunotherapy and had a more favorable prognosis.

Conclusions: Our study innovatively provided a comprehensive analysis of FPGs in GC, and constructed the FPG_Score system for stratification of individual patients, so as to predict its benefit from immunotherapy and prognosis.

References

Schrock A, Ouyang C, Sandhu J, Sokol E, Jin D, Ross J . Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer. Ann Oncol. 2019; 30(7):1096-1103. DOI: 10.1093/annonc/mdz134. View

Li Y, Xia J, Shao F, Zhou Y, Yu J, Wu H . Sorafenib induces mitochondrial dysfunction and exhibits synergistic effect with cysteine depletion by promoting HCC cells ferroptosis. Biochem Biophys Res Commun. 2020; 534:877-884. DOI: 10.1016/j.bbrc.2020.10.083. View

Li Y, Wang X, Huang Z, Zhou Y, Xia J, Hu W . CISD3 inhibition drives cystine-deprivation induced ferroptosis. Cell Death Dis. 2021; 12(9):839. PMC: 8426496. DOI: 10.1038/s41419-021-04128-2. View

Puliga E, Corso S, Pietrantonio F, Giordano S . Microsatellite instability in Gastric Cancer: Between lights and shadows. Cancer Treat Rev. 2021; 95:102175. DOI: 10.1016/j.ctrv.2021.102175. View

Tang R, Xu J, Zhang B, Liu J, Liang C, Hua J . Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. J Hematol Oncol. 2020; 13(1):110. PMC: 7418434. DOI: 10.1186/s13045-020-00946-7. View

Merino D, McShane L, Fabrizio D, Funari V, Chen S, White J . Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project. J Immunother Cancer. 2020; 8(1). PMC: 7174078. DOI: 10.1136/jitc-2019-000147. View

Liao P, Wang W, Wang W, Kryczek I, Li X, Bian Y . CD8 T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell. 2022; 40(4):365-378.e6. PMC: 9007863. DOI: 10.1016/j.ccell.2022.02.003. View

Zhang S, Zheng W, Jiang D, Xiong H, Liao G, Yang X . Systematic Chromatin Accessibility Analysis Based on Different Immunological Subtypes of Clear Cell Renal Cell Carcinoma. Front Oncol. 2021; 11:575425. PMC: 8085385. DOI: 10.3389/fonc.2021.575425. View

Morihiro T, Kuroda S, Kanaya N, Kakiuchi Y, Kubota T, Aoyama K . PD-L1 expression combined with microsatellite instability/CD8+ tumor infiltrating lymphocytes as a useful prognostic biomarker in gastric cancer. Sci Rep. 2019; 9(1):4633. PMC: 6420501. DOI: 10.1038/s41598-019-41177-2. View

10.

Deng B, Jiao B, Liu Y, Li Y, Wang G . BIX-01294 enhanced chemotherapy effect in gastric cancer by inducing GSDME-mediated pyroptosis. Cell Biol Int. 2020; 44(9):1890-1899. PMC: 7496303. DOI: 10.1002/cbin.11395. View

11.

Liang C, Zhang X, Yang M, Dong X . Recent Progress in Ferroptosis Inducers for Cancer Therapy. Adv Mater. 2019; 31(51):e1904197. DOI: 10.1002/adma.201904197. View

12.

Ashizawa N, Shimizu H, Shoda K, Furuya S, Akaike H, Hosomura N . NADPH oxidase 5 has a crucial role in cellular motility of colon cancer cells. Int J Oncol. 2021; 59(2). DOI: 10.3892/ijo.2021.5243. View

13.

Cookson B, Brennan M . Pro-inflammatory programmed cell death. Trends Microbiol. 2001; 9(3):113-4. DOI: 10.1016/s0966-842x(00)01936-3. View

14.

Yao F, Zhan Y, Pu Z, Lu Y, Chen J, Deng J . LncRNAs Target Ferroptosis-Related Genes and Impair Activation of CD4 T Cell in Gastric Cancer. Front Cell Dev Biol. 2021; 9:797339. PMC: 8710671. DOI: 10.3389/fcell.2021.797339. View

15.

Hao S, Yu J, He W, Huang Q, Zhao Y, Liang B . Cysteine Dioxygenase 1 Mediates Erastin-Induced Ferroptosis in Human Gastric Cancer Cells. Neoplasia. 2017; 19(12):1022-1032. PMC: 5686465. DOI: 10.1016/j.neo.2017.10.005. View

16.

Wang X, Wu W, Gao J, Li Z, Dong B, Lin X . Autophagy inhibition enhances PD-L1 expression in gastric cancer. J Exp Clin Cancer Res. 2019; 38(1):140. PMC: 6440013. DOI: 10.1186/s13046-019-1148-5. View

17.

Zhou C, Wang L, Hu W, Tang L, Zhang P, Gao Y . CDC25C is a prognostic biomarker and correlated with mitochondrial homeostasis in pancreatic adenocarcinoma. Bioengineered. 2022; 13(5):13089-13107. PMC: 9275923. DOI: 10.1080/21655979.2022.2078940. View

18.

Runa F, Hamalian S, Meade K, Shisgal P, Gray P, Kelber J . Tumor microenvironment heterogeneity: challenges and opportunities. Curr Mol Biol Rep. 2018; 3(4):218-229. PMC: 5802345. DOI: 10.1007/s40610-017-0073-7. View

19.

Yaghoubi N, Soltani A, Ghazvini K, Hassanian S, Hashemy S . PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer. Biomed Pharmacother. 2018; 110:312-318. DOI: 10.1016/j.biopha.2018.11.105. View

20.

Rooney M, Shukla S, Wu C, Getz G, Hacohen N . Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell. 2015; 160(1-2):48-61. PMC: 4856474. DOI: 10.1016/j.cell.2014.12.033. View